Difference between revisions of "Sorafenib Dosing Nomogram"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "{{#lst:Section editor transclusions|peds}} <big>''This page contains studies that were specific to pediatric populations. For the more general AML page, follow Acute myeloid...")
 
Line 7: Line 7:
 
|}
 
|}
 
{{TOC limit|limit=3}}
 
{{TOC limit|limit=3}}
 +
 +
=AAML1031 Sorafenib Dosing Nomogram==
 +
 +
{| class="wikitable" style="width: 40%; text-align:center;"
 +
! style="width: 25%" |BSA Range (m<sup>2</sup>)
 +
! style="width: 25%" |Dose Level 0 (100 mg/m<sup>2</sup>/day once daily)
 +
! style="width: 25%" |Dose Level 1 (200 mg/m<sup>2</sup>/day once daily)
 +
! style="width: 25%" |Dose Level 2 (300 mg/m<sup>2</sup>/day divided BID)
 +
|-
 +
|≤ 0.35
 +
|50 mg x 4 days/week,
 +
0 x 3 day/week
 +
(200 mg)
 +
|50 mg x 5 days/week,
 +
100 mg x 2 days/week
 +
(450 mg)
 +
|50 mg twice daily x 7 days/week
 +
(700 mg)
 +
|-
 +
|0.36 - 0.4
 +
|50 mg x 5 days/week,
 +
0 x 2 day/week
 +
(250 mg)
 +
|50 mg x 4 days/week,
 +
100 mg x 3 days/week
 +
(500 mg)
 +
|50 mg twice daily x 6 days/week +
 +
100 mg twice daily x 1 day/week
 +
(800 mg)
 +
|-
 +
 +
|-
 +
 +
|}

Revision as of 00:19, 3 September 2021

Section editor transclusions This page contains studies that were specific to pediatric populations. For the more general AML page, follow this link.

0 regimens on this page
0 variants on this page


AAML1031 Sorafenib Dosing Nomogram=

BSA Range (m2) Dose Level 0 (100 mg/m2/day once daily) Dose Level 1 (200 mg/m2/day once daily) Dose Level 2 (300 mg/m2/day divided BID)
≤ 0.35 50 mg x 4 days/week,

0 x 3 day/week (200 mg)

50 mg x 5 days/week,

100 mg x 2 days/week (450 mg)

50 mg twice daily x 7 days/week

(700 mg)

0.36 - 0.4 50 mg x 5 days/week,

0 x 2 day/week (250 mg)

50 mg x 4 days/week,

100 mg x 3 days/week (500 mg)

50 mg twice daily x 6 days/week +

100 mg twice daily x 1 day/week (800 mg)